Attendance at Swindon’s Festival of Tomorrow doubled this year, as thousands turned out to explore its biggest ever programme ...
The transaction – first announced in February – would see Novo Nordisk's parent company Novo Holdings buy contract development and manufacturing organisation (CDMO) Catalent outright for $16.5 ...
Eli Lilly has called on financial regulators to look into the antitrust implications of Novo Holdings' purchase of Catalent and the sale of three manufacturing facilities to Novo Nordisk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results